Literature DB >> 11318955

Long-term exposure to high glucose up-regulates VCAM-induced endothelial cell adhesiveness to PBMC.

C Esposito1, G Fasoli, A R Plati, N Bellotti, M M Conte, F Cornacchia, A Foschi, T Mazzullo, L Semeraro, A Dal Canton.   

Abstract

BACKGROUND: The changes induced on endothelial cells by a long-term exposure to high glucose, a situation that mimics the hyperglycemia of diabetics, have not yet been determined. We compared short- and long-term effects of elevated glucose on macrovascular and microvascular endothelial cells.
METHODS: Endothelial cells were grown in high-glucose media for 24 hours and for 8 weeks. Cell proliferation was evaluated by cell counting, apoptosis and expression of adhesion molecules by flow cytometry; nitric oxide (NO) by measuring the concentration of nitrite/nitrate in the cell supernatant; alpha 2(IV) collagen mRNA and protein by reverse transcriptase-polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. The adhesion of peripheral blood mononuclear cells (PBMCs) to endothelial cells was evaluated by adhesion assay. In some experiments, endothelial cells were preincubated with anti-vascular cell adhesion molecule-1 (VCAM-1) and anti-receptor for advanced glycation end product (RAGE) blocking antibodies.
RESULTS: At 24 hours, but not at 8 weeks, high glucose increased endothelial cell proliferation and apoptosis. High glucose did not modify NO synthesis at 24 hours and 8 weeks. Collagen production and expression were increased only after eight weeks. VCAM-1 but not intercellular adhesion molecule-1 was up-regulated after 8 weeks, a change not observed after 24 hours. The adhesion of PBMCs was significantly increased at eight weeks and was completely abrogated by anti--VCAM-1 and by anti-RAGE antibodies. After 24 hours, there was a modest increase of PBMC adhesion that was not blunted by anti-RAGE antibodies.
CONCLUSIONS: Increased adhesion of PBMCs, caused by up-regulation of VCAM-1 with a mechanism involving advanced glycation end product (AGE) adducts, and augmented collagen deposition are critical effects of long-term high glucose on endothelial cells, and may eventually promote the atherosclerotic process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11318955     DOI: 10.1046/j.1523-1755.2001.0590051842.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  22 in total

Review 1.  Advanced glycation end products, diabetes and ageing.

Authors:  N Nass; B Bartling; A Navarrete Santos; R J Scheubel; J Börgermann; R E Silber; A Simm
Journal:  Z Gerontol Geriatr       Date:  2007-10       Impact factor: 1.281

2.  Emodin-6-O-β-D--glucoside inhibits high-glucose-induced vascular inflammation.

Authors:  Wonhwa Lee; Sae-Kwang Ku; Doohyun Lee; Taeho Lee; Jong-Sup Bae
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

3.  Orientin inhibits high glucose-induced vascular inflammation in vitro and in vivo.

Authors:  Sae-Kwang Ku; Soyoung Kwak; Jong-Sup Bae
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

4.  Hyperoside inhibits high-glucose-induced vascular inflammation in vitro and in vivo.

Authors:  Sae-Kwang Ku; Soyoung Kwak; O-Jun Kwon; Jong-Sup Bae
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

5.  Fisetin inhibits high-glucose-induced vascular inflammation in vitro and in vivo.

Authors:  Soyoung Kwak; Sae-Kwang Ku; Jong-Sup Bae
Journal:  Inflamm Res       Date:  2014-06-13       Impact factor: 4.575

6.  Aspalathin and Nothofagin from Rooibos (Aspalathus linearis) inhibits high glucose-induced inflammation in vitro and in vivo.

Authors:  Sae-Kwang Ku; Soyoung Kwak; Yaesol Kim; Jong-Sup Bae
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

7.  Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption.

Authors:  Mohanraj Rajesh; Partha Mukhopadhyay; Sándor Bátkai; György Haskó; Lucas Liaudet; Viktor R Drel; Irina G Obrosova; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-03-23       Impact factor: 4.733

8.  Methylglyoxal triggers human aortic endothelial cell dysfunction via modulation of the KATP/MAPK pathway.

Authors:  Yihan Wang; Leo M Hall; Marisa Kujawa; Hainan Li; Xiang Zhang; Megan O'Meara; Tomomi Ichinose; Jie-Mei Wang
Journal:  Am J Physiol Cell Physiol       Date:  2019-04-17       Impact factor: 4.249

Review 9.  Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.

Authors:  Maura Knapp; Xin Tu; Rongxue Wu
Journal:  Acta Pharmacol Sin       Date:  2018-06-04       Impact factor: 6.150

Review 10.  Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies.

Authors:  Gaia Spinetti; Nicolle Kraenkel; Costanza Emanueli; Paolo Madeddu
Journal:  Cardiovasc Res       Date:  2008-02-15       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.